Search

Your search keyword '"Baveja, Sujata"' showing total 130 results
Start Over Author "Baveja, Sujata"
130 results on '"Baveja, Sujata"'

1. Health-care-associated bloodstream and urinary tract infections in a network of hospitals in India: a multicentre, hospital-based, prospective surveillance study

Author

Malhotra, Rajesh, Katoch, Omika, Katyal, Sonal, Khurana, Surbhi, Kumar, Subodh, Agrawal, Richa, Dev Soni, Kapil, Sagar, Sushma, Wig, Naveet, Garg, Pramod, Kapil, Arti, Lodha, Rakesh, Sahu, Manoj, Misra, M.C., Lamba, Mamta, Jain, Shristi, Paul, Hema, Sarojini Michael, Joy, Kumar Bhatia, Pradeep, Singh, Kuldeep, Gupta, Neeraj, Khera, Daisy, Himanshu, D, Verma, Sheetal, Gupta, Prashant, Kumar, Mala, Pervez Khan, Mohammed, Gupta, Sarika, Kalwaje Eshwara, Vandana, Varma, Muralidhar, Attal, Ruchita, Sudhaharan, Sukanya, Goel, Neeraj, Saigal, Saurabh, Khadanga, Sagar, Gupta, Ayush, Thirunarayan, M.A., Sethuraman, Nandini, Roy, Ujjaini, Jyoti Raj, Hirak, D'Souza, Desma, Chandy, Mammen, Mukherjee, Sudipta, Kumar Roy, Manas, Goel, Gaurav, Tripathy, Swagata, Misra, Satyajeet, Dey, Anupam, Misra, Tushar, Ranjan Das, Rashmi, Bashir, Gulnaz, Nazir, Shaista, Ranjana Devi, Khuraijam, Chaoba Singh, Langpoklakpam, Bhargava, Anudita, Gaikwad, Ujjwala, Vaghela, Geeta, Sukharamwala, Tanvi, Ch. Phukan, Anil, Lyngdoh, Clarissa, Saksena, Rushika, Sharma, Rajeev, Velayudhan, Anoop, Mathur, Purva, Malpiedi, Paul, Walia, Kamini, Srikantiah, Padmini, Gupta, Sunil, Lohiya, Ayush, Chakrabarti, Arunaloke, Ray, Pallab, Biswal, Manisha, Taneja, Neelam, Rupali, Priscilla, Balaji, Veeraraghavan, Rodrigues, Camilla, Lakshmi Nag, Vijaya, Tak, Vibhor, Venkatesh, Vimala, Mukhopadhyay, Chiranjay, Deotale, Vijayshri, Padmaja, Kanne, Wattal, Chand, Bhattacharya, Sanjay, Karuna, Tadepalli, Behera, Bijayini, Singh, Sanjeev, Nath, Reema, Ray, Raja, Baveja, Sujata, Fomda, Bashir A, Sulochana Devi, Khumanthem, Das, Padma, Khandelwal, Neeta, Verma, Prachi, Bhattacharyya, Prithwis, Gaind, Rajni, Kapoor, Lata, Gupta, Neil, Sharma, Aditya, VanderEnde, Daniel, Siromany, Valan, Laserson, Kayla, and Guleria, Randeep

Published
2022
Full Text
View/download PDF

3. Continual Improvement in Clinical Bacteriology Laboratory with Quality Indicators: A Retrospective Observational Study.

Author

RANDIVE, MRUDUL, SOUZA, DESMA D., SHINDE, ALKA, NAIR, MADHURIMA, CHAURASIA, ANKITA, JAMWAL, ASHIMA, CHAVAN, SUJATA, and BAVEJA, SUJATA

Subjects
PATHOLOGICAL laboratories, MEDICAL microbiology, QUALITY control, SCIENTIFIC observation, QUALITY of service
Abstract

Introduction: Healthcare management is undergoing significant changes with the evolution of new and re-emerging infections. A clinical microbiologist plays an important role in giving an accurate and timely report to the clinicians. Quality Indicators (QIs) act as a measure of the quality of services offered by the laboratory and are tools to monitor and evaluate the laboratory's performance throughout the Total Testing Process (TTP). Aim: To measure the performance of the clinical bacteriology laboratory using QIs. Materials and Methods: A retrospective study was conducted in the Department of Microbiology at Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai, Maharashtra, India. The study evaluated QIs from the records of 94,624 samples received in the bacteriology section of the clinical Microbiology laboratory between January 2018 and March 2021. Data analysis was conducted over a six-month period from December 2021 to May 2022. In 2018, one QI was identified for each phase, with an additional QI added in each phase to the pre-existing QI in 2019. In 2020, a QI was added in the preanalytical phase only. In 2021, the acceptable limit for one preanalytical QI was reduced from 2% to 1%. Data analysis was performed using an Excel sheet. Results: Data from records of 94,624 clinical bacteriology samples collected over 39 months were analyzed retrospectively. The preanalytical indicators included the number of samples rejected (135, 0.14%) and the number of requisition forms with three patient identifiers (59,645, 93.95%). Analytical phase QIs consisted of the average External Quality Assurance Scheme (EQAS) performance score (97.44% from January 2018 to March 2021) and outliers in the Internal Quality Control (IQC) (25 from January 2019 till March 2021). Failures in the IQC were not assessed in 2018. Postanalytical phase QIs included Turnaround Time (TAT) (average of 2.55 days for aerobic growth) and reporting time for critical alerts, which was within 24 hours of alert finding (100% for smear and culture-positive results). Conclusion: Regular monitoring of QIs helps to identify potential errors. This laboratory chose to analyse and monitor its processes using practically feasible QIs. It was found that the laboratory consistently maintained its performance throughout the study period. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

4. Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India

Author

Gokhale, Yojana, Mehta, Rakshita, Kulkarni, Uday, Karnik, Nitin, Gokhale, Sushant, Sundar, Uma, Chavan, Swati, Kor, Akshay, Thakur, Sonal, Trivedi, Trupti, Kumar, Naveen, Baveja, Sujata, Wadal, Aniket, Kolte, Shaonak, Deolankar, Aukshan, Pednekar, Sangeeta, Kalekar, Lalana, Padiyar, Rupal, Londhe, Charulata, Darole, Pramod, Pol, Sujata, Gokhe, Seema Bansode, Padwal, Namita, Pandey, Dharmendra, Yadav, Dhirendra, Joshi, Anagha, Badgujar, Harshal, Trivedi, Mayuri, Shah, Priyanshu, and Bhavsar, Prerna

Published
2021
Full Text
View/download PDF

11. Bacteriological profile and antimicrobial susceptibility pattern of cerebrospinal fluid shunt infections in infants and children

Author

Chaurasia, Ankita, Shinde, Alka, and Baveja, Sujata

Subjects
United States. Centers for Disease Control and Prevention, Sulbactam, Infection, Antibacterial agents, Methicillin, Disease susceptibility, Health
Abstract

Byline: Ankita. Chaurasia, Alka. Shinde, Sujata. Baveja Background: Despite the advent of modern neurosurgical techniques, new antibiotics, and modern imaging techniques, infection after ventriculoperitoneal (VP) shunt insertion and/or ventriculostomy is [...]

Published
2021

12. In Vitro Activity of Two Cefepime-Based Novel Combinations, Cefepime/Taniborbactam and Cefepime/Zidebactam, against Carbapenemase-Expressing Enterobacterales Collected in India

Author

Bakthavatchalam, Yamuna Devi, primary, Elangovan, Divyaa, additional, Jaganathan, Subha Vajjiravelu, additional, Subburaju, Nivedhana, additional, Shankar, Abirami, additional, Manokaran, Yuvasri, additional, J., Sudarsana, additional, Devi, Rema, additional, Baveja, Sujata, additional, Devi, Sheela, additional, S., Jayakumar, additional, Bhattacharya, Sanjay, additional, S. M., Rudresh, additional, Yesudhason, Bineshlal, additional, Shetty, Vignesh, additional, Mutreja, Ankur, additional, Manesh, Abi, additional, Varghese, George M., additional, Marwick, Charis A., additional, Parcell, Benjamin J., additional, Gilbert, Ian H., additional, and Veeraraghavan, Balaji, additional

Published
2023
Full Text
View/download PDF

13. India-discovered levonadifloxacin & alalevonadifloxacin: A review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-care

Author

Veeraraghavan, Balaji, primary, Bakthavatchalam, Yamuna Devi, additional, Manesh, Abi, additional, Lal, Binesh, additional, Swaminathan, Subramanian, additional, Ansari, Abdul, additional, Subbareddy, K., additional, Rangappa, Pradeep, additional, Choudhuri, Anirban Hom, additional, Nagvekar, Vasant, additional, Mehta, Yatin, additional, Appalaraju, Boppe, additional, Baveja, Sujata, additional, Baliga, Shrikala, additional, Shenoy, Suchitra, additional, Bhardwaj, Renu, additional, Kongre, Vaishali, additional, Dattatraya, Gogi Suresh, additional, Verma, Binita, additional, Mukherjee, D.N., additional, Gupta, Shalini, additional, Shanmugam, Priyadarshini, additional, Iravane, Jyoti, additional, Mishra, Sudhi Ranjan, additional, Barman, Purabi, additional, Chopra, Shimpi, additional, Hariharan, Meenakshi, additional, Surpam, Rajendra, additional, Pratap, Rana, additional, Turbadkar, Dilip, additional, and Taklikar, Shripad, additional

Published
2023
Full Text
View/download PDF

14. A self-reported survey on the implementation of infection prevention and control elements in Indian hospitals, part of a HAI surveillance network: Results from 23 hospitals conducting a standardized IPC assessment

Author

Katyal, Sonal, primary, Srivastav, Sharad, additional, Katoch, Omika, additional, Rodrigues, Camilla, additional, Rupali, Priscilla, additional, Chakrabarti, Arunaloke, additional, Ray, Pallab, additional, Biswal, Manisha, additional, Tak, Vibhor, additional, Nath, Reema, additional, Mukhopadhyay, Chiranjay, additional, Bhattacharya, Sanjay, additional, Padmaja, Kanne, additional, Deotale, Vijayshri, additional, Venkatesh, Vimala, additional, Wattal, Chand, additional, MA, Thirunarayan, additional, Nag, Vijaya Lakshmi, additional, Ray, Raja, additional, Behera, Bijayini, additional, Baveja, Sujata, additional, Karuna, Tadepalli, additional, Singh, Sanjeev K, additional, Fomda, Bashir, additional, Devi, Sulochana K, additional, Das, Padma, additional, Khandelwal, Neeta, additional, Verma, Prachi, additional, Thangavelu, Premkumar, additional, Nazir, Shaista, additional, Eshwara, Vandana K, additional, Varma, Muralidhar, additional, Mishra, Tushar S, additional, Das, Rashmi R, additional, Malhotra, Rajesh, additional, Walia, Kamini, additional, Guleria, Randeep, additional, and Mathur, Purva, additional

Published
2023
Full Text
View/download PDF

17. Health-care-associated bloodstream and urinary tract infections in a network of hospitals in India: a multicentre, hospital-based, prospective surveillance study

Author

Mathur, Purva, primary, Malpiedi, Paul, additional, Walia, Kamini, additional, Srikantiah, Padmini, additional, Gupta, Sunil, additional, Lohiya, Ayush, additional, Chakrabarti, Arunaloke, additional, Ray, Pallab, additional, Biswal, Manisha, additional, Taneja, Neelam, additional, Rupali, Priscilla, additional, Balaji, Veeraraghavan, additional, Rodrigues, Camilla, additional, Lakshmi Nag, Vijaya, additional, Tak, Vibhor, additional, Venkatesh, Vimala, additional, Mukhopadhyay, Chiranjay, additional, Deotale, Vijayshri, additional, Padmaja, Kanne, additional, Wattal, Chand, additional, Bhattacharya, Sanjay, additional, Karuna, Tadepalli, additional, Behera, Bijayini, additional, Singh, Sanjeev, additional, Nath, Reema, additional, Ray, Raja, additional, Baveja, Sujata, additional, Fomda, Bashir A, additional, Sulochana Devi, Khumanthem, additional, Das, Padma, additional, Khandelwal, Neeta, additional, Verma, Prachi, additional, Bhattacharyya, Prithwis, additional, Gaind, Rajni, additional, Kapoor, Lata, additional, Gupta, Neil, additional, Sharma, Aditya, additional, VanderEnde, Daniel, additional, Siromany, Valan, additional, Laserson, Kayla, additional, Guleria, Randeep, additional, Malhotra, Rajesh, additional, Katoch, Omika, additional, Katyal, Sonal, additional, Khurana, Surbhi, additional, Kumar, Subodh, additional, Agrawal, Richa, additional, Dev Soni, Kapil, additional, Sagar, Sushma, additional, Wig, Naveet, additional, Garg, Pramod, additional, Kapil, Arti, additional, Lodha, Rakesh, additional, Sahu, Manoj, additional, Misra, M.C., additional, Lamba, Mamta, additional, Jain, Shristi, additional, Paul, Hema, additional, Sarojini Michael, Joy, additional, Kumar Bhatia, Pradeep, additional, Singh, Kuldeep, additional, Gupta, Neeraj, additional, Khera, Daisy, additional, Himanshu, D, additional, Verma, Sheetal, additional, Gupta, Prashant, additional, Kumar, Mala, additional, Pervez Khan, Mohammed, additional, Gupta, Sarika, additional, Kalwaje Eshwara, Vandana, additional, Varma, Muralidhar, additional, Attal, Ruchita, additional, Sudhaharan, Sukanya, additional, Goel, Neeraj, additional, Saigal, Saurabh, additional, Khadanga, Sagar, additional, Gupta, Ayush, additional, Thirunarayan, M.A., additional, Sethuraman, Nandini, additional, Roy, Ujjaini, additional, Jyoti Raj, Hirak, additional, D'Souza, Desma, additional, Chandy, Mammen, additional, Mukherjee, Sudipta, additional, Kumar Roy, Manas, additional, Goel, Gaurav, additional, Tripathy, Swagata, additional, Misra, Satyajeet, additional, Dey, Anupam, additional, Misra, Tushar, additional, Ranjan Das, Rashmi, additional, Bashir, Gulnaz, additional, Nazir, Shaista, additional, Ranjana Devi, Khuraijam, additional, Chaoba Singh, Langpoklakpam, additional, Bhargava, Anudita, additional, Gaikwad, Ujjwala, additional, Vaghela, Geeta, additional, Sukharamwala, Tanvi, additional, Ch. Phukan, Anil, additional, Lyngdoh, Clarissa, additional, Saksena, Rushika, additional, Sharma, Rajeev, additional, and Velayudhan, Anoop, additional

Published
2022
Full Text
View/download PDF

18. Self-reported survey on infection prevention and control structures in healthcare facilities part of a national level healthcare associated infection surveillance network in India, 2019

Author

Katoch, Omika, primary, Katyal, Sonal, additional, Srivastav, Sharad, additional, Rodrigues, Camilla, additional, Rupali, Priscilla, additional, Chakrabarti, Arunaloke, additional, Ray, Pallab, additional, Tak, Vibhor, additional, Biswal, Manisha, additional, Nath, Reema, additional, Mukhopadhyay, Chiranjay, additional, Bhattacharya, Sanjay, additional, Padmaja, Kanne, additional, Deotale, Vijayshri, additional, Venkatesh, Vimala, additional, Wattal, Chand, additional, MA, Thirunarayan, additional, Nag, Vijaya Lakshmi, additional, Ray, Raja, additional, Behera, Bijayini, additional, Baveja, Sujata, additional, Karuna, Tadepalli, additional, Singh, Sanjeev K., additional, Fomda, Bashir, additional, devi, Sulochana khumanthem, additional, Das, Padma, additional, Khandelwal, Neeta, additional, Verma, Prachi, additional, Gaind, Rajni, additional, Bhattacharyya, Prithwis, additional, Kumar, Puneet, additional, Srivastava, Ashutosh, additional, Iravane, Jyoti, additional, Majumdar, Tapan, additional, Sharma, Rajni, additional, Sankara, Dhanapaul, additional, Kalwaje Eshwara, Vandana, additional, Varma, Muralidhar, additional, Nazir, Shaista, additional, Tripathy, Swagata, additional, Mishra, Satyajeet, additional, Dey, Anupam, additional, Thangavelu, Premkumar, additional, Kapoor, Lata, additional, Malhotra, Rajesh, additional, Walia, Kamini, additional, Guleria, Randeep, additional, and Mathur, Purva, additional

Published
2022
Full Text
View/download PDF

19. Assessment of Core Capacities for Antimicrobial Stewardship Practices in Indian Hospitals: Report from a Multicentric Initiative of Global Health Security Agenda

Author

Lyngdoh Clarissa, Nazir Shaista, C Phukan Anil, Biswal Manisha, K.Bhatia Pradeep, C Singh Langpoklakpam, Kapoor Lata, Guleria Randeep, Singh Sanjeev, Rodrigues Camilla, Wattal Chand, Baveja Sujata, Misra Satyajeet, Taneja Neelam, Sukharamwala Tanvi, Tak Vibhor, Singh Kuldeep, Dey Anupam, C Misra Mahesh, Walia Kamini, Sen Sourav, Das Padma, Bashir Gulnaz, Lamba Mamta, Nag Vijayalakshmi, Katyal Sonal, Malhotra Rajesh, Venkatesh Vimala, Bijayini Behera, Kumar Subodh, Tripathy Swagata, Rupali Priscilla, D’Souza Desma, Vaghela Geeta, Kapil Arti, Khandelwal Neeta, Verma Prachi, Tadepalli Karuna, Goel Neeraj, Wig Naveet, Sudhaharan Sukanya, A Fomda Bashir, S Mishra Tushar, Varma Muralidhar, Attal Ruchita, Katoch Omika, M A Thirunarayan, Jacob Ebor, Jain Shristi, Bhattacharyya Prithwis, Gaind Rajni, Khera Daisy, Garg Pramod, KE Vandana, K Roy Manas, Ray Pallab, Nath Reema, Gupta Sunil, Deotale Vijayshri, Padmaja Kanne, Bhargava Anudita, Saikia Lahri, Gaikwad Ujjwala, Mathur Purva, Ray Raja, J Raj Hirak, Mukherjee Sudipta, Sahu Manoj, Subaramani K, Mukhopadhyay Chiranjay, Bhattacharya Sanjay, Chandy Mammen, Saksena Rushika, Balaji Veeraraghavan, Ohri Vinod, Goel Gaurav, Khurana Surbhi, Sagar Sushma, Gupta Neeraj, R Devi Khuraijam, Saigal Saurabh, Devi Sulochana, and Chakrabarti Arunaloke

Subjects
0301 basic medicine, Microbiology (medical), medicine.medical_specialty, assessment, 030106 microbiology, Immunology, lcsh:QR1-502, Psychological intervention, Microbiology, antimicrobials, lcsh:Microbiology, Antimicrobial Stewardship, 03 medical and health sciences, stewardship, 0302 clinical medicine, Immunology and Microbiology (miscellaneous), medicine, Global health, Humans, Immunology and Allergy, Antimicrobial stewardship, 030212 general & internal medicine, Medical prescription, General Immunology and Microbiology, business.industry, india, Capacity building, Private sector, Hospitals, Checklist, Anti-Bacterial Agents, global health security agenda, Infectious Diseases, Family medicine, Accountability, business
Abstract

Introduction: Antimicrobial-resistant HAI (Healthcare associated infection) are a global challenge due to their impact on patient outcome. Implementation of antimicrobial stewardship programmes (AMSP) is needed at institutional and national levels. Assessment of core capacities for AMSP is an important starting point to initiate nationwide AMSP. We conducted an assessment of the core capacities for AMSP in a network of Indian hospitals, which are part of the Global Health Security Agenda-funded work on capacity building for AMR-HAIs. Subjects and Methods: The Centers for Disease Control and Prevention's core assessment checklist was modified as per inputs received from the Indian network. The assessment tool was filled by twenty hospitals as a self-administered questionnaire. The results were entered into a database. The cumulative score for each question was generated as average percentage. The scores generated by the database were then used for analysis. Results and Conclusion: The hospitals included a mix of public and private sector hospitals. The network average of positive responses for leadership support was 45%, for accountability; the score was 53% and for key support for AMSP, 58%. Policies to support optimal antibiotic use were present in 59% of respondents, policies for procurement were present in 79% and broad interventions to improve antibiotic use were scored as 33%. A score of 52% was generated for prescription-specific interventions to improve antibiotic use. Written policies for antibiotic use for hospitalised patients and outpatients were present on an average in 72% and 48% conditions, respectively. Presence of process measures and outcome measures was scored at 40% and 49%, respectively, and feedback and education got a score of 53% and 40%, respectively. Thus, Indian hospitals can start with low-hanging fruits such as developing prescription policies, restricting the usage of high antibiotics, enforcing education and ultimately providing the much-needed leadership support.

Published
2019
Full Text
View/download PDF

20. Secondary Infections in Hospitalized COVID-19 Patients: Indian Experience

Author

Vijay,Sonam, Bansal,Nitin, Rao,Brijendra Kumar, Veeraraghavan,Balaji, Rodrigues,Camilla, Wattal,Chand, Goyal,Jagdish Prasad, Tadepalli,Karuna, Mathur,Purva, Venkateswaran,Ramanathan, Venkatasubramanian,Ramasubramanian, Khadanga,Sagar, Bhattacharya,Sanjay, Mukherjee,Sudipta, Baveja,Sujata, Sistla,Sujatha, Panda,Samiran, Walia,Kamini, Vijay,Sonam, Bansal,Nitin, Rao,Brijendra Kumar, Veeraraghavan,Balaji, Rodrigues,Camilla, Wattal,Chand, Goyal,Jagdish Prasad, Tadepalli,Karuna, Mathur,Purva, Venkateswaran,Ramanathan, Venkatasubramanian,Ramasubramanian, Khadanga,Sagar, Bhattacharya,Sanjay, Mukherjee,Sudipta, Baveja,Sujata, Sistla,Sujatha, Panda,Samiran, and Walia,Kamini

Abstract

Sonam Vijay,1 Nitin Bansal,1 Brijendra Kumar Rao,2 Balaji Veeraraghavan,3 Camilla Rodrigues,4 Chand Wattal,5 Jagdish Prasad Goyal,6 Karuna Tadepalli,7 Purva Mathur,8 Ramanathan Venkateswaran,9 Ramasubramanian Venkatasubramanian,10 Sagar Khadanga,11 Sanjay Bhattacharya,12 Sudipta Mukherjee,13 Sujata Baveja,14 Sujatha Sistla,15 Samiran Panda,1 Kamini Walia1 1Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi, India; 2Institute of Critical Medicine, Sir Ganga Ram Hospital, New Delhi, India; 3Department of Clinical Microbiology, Christian Medical College, Vellore, India; 4Department of Microbiology, PD Hinduja Hospital, Mumbai, Maharashtra, India; 5Department of Clinical Microbiology, Sir Ganga Ram Hospital, New Delhi, India; 6Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, India; 7Department of Microbiology, All India Institute of Medical Sciences, Bhopal, India; 8Department of Laboratory Medicine, Jai Prakash Narayan Apex Trauma Center, All India Institute of Medical Sciences, New Delhi, India; 9Department of Medicine, JIPMER, Pondicherry, India; 10Department of Infectious Diseases, Apollo Hospital, Chennai, Tamil Nadu, India; 11Department of Medicine, All India Institute of Medical Sciences, Bhopal, India; 12Department of Microbiology, Tata Medical Center, Kolkata, West Bengal, India; 13Department of Critical Care Medicine, Tata Medical Center, Kolkata, West Bengal, India; 14Department of Microbiology, Lokmanya Tilak Municipal General Hospital, Mumbai, India; 15Department of Microbiology, JIPMER, Pondicherry, IndiaCorrespondence: Kamini WaliaDivision of Epidemiology and Communicable Diseases, Indian Council of Medical Research, Ansari Nagar, New Delhi, 110029, IndiaEmail waliakamini@yahoo.co.inPurpose: Critically ill coronavirus disease 2019 (COVID-19) patients need hospitalization which increases their risk of acquiring secondary bacterial and fungal infections. The practice of empiric antimi

Published
2021

21. Secondary Infections in Hospitalized COVID-19 Patients: Indian Experience

Author

Vijay, Sonam, primary, Bansal, Nitin, additional, Rao, Brijendra Kumar, additional, Veeraraghavan, Balaji, additional, Rodrigues, Camilla, additional, Wattal, Chand, additional, Goyal, Jagdish Prasad, additional, Tadepalli, Karuna, additional, Mathur, Purva, additional, Venkateswaran, Ramanathan, additional, Venkatasubramanian, Ramasubramanian, additional, Khadanga, Sagar, additional, Bhattacharya, Sanjay, additional, Mukherjee, Sudipta, additional, Baveja, Sujata, additional, Sistla, Sujatha, additional, Panda, Samiran, additional, and Walia, Kamini, additional

Published
2021
Full Text
View/download PDF

22. Activity of novel lactone ketolide nafithromycin against multicentric invasive and non-invasive pneumococcal isolates collected in India

Author

Veeraraghavan, Balaji, primary, Varghese, Rosemol, additional, Saigal, Karnika, additional, Balasubramanian, S, additional, Bai, P Sulochana Putli, additional, Lal Y, Binesh, additional, Neeravi, Ayyanraj, additional, Baskar, Pavithra, additional, Anandhan, Kavipriya, additional, Kumar, C P Girish, additional, Jayaraman, Yuvraj, additional, Nag, Vijaya Lakshmi, additional, Baveja, Sujata, additional, J, Bhavana, additional, Joshi, Shrikrishna A, additional, and Iyer, Ranganathan, additional

Published
2021
Full Text
View/download PDF

25. Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: A retrospective cohort study with follow-up from Mumbai, India

Author

Gokhale, Yojana, primary, Mehta, Rakshita, additional, Kulkarni, Uday, additional, Karnik, Nitin, additional, Gokhale, Sushant, additional, Sundar, Uma, additional, Chavan, Swati, additional, Kor, Akshay, additional, Thakur, Sonal, additional, Triwedi, Tripti, additional, Kumar, Naveen, additional, Baveja, Sujata, additional, Wadal, Aniket, additional, Kolte, Shaonak, additional, Deolankar, Aukshan, additional, Pednekar, Sangeeta, additional, Kalekar, Lalana, additional, Padiyar, Rupal, additional, Londhe, Charulata, additional, Darole, Pramod, additional, Pol, Sujata, additional, Gokhe, Seema Bansode, additional, Padwal, Namita, additional, Pandey, Dharmendra, additional, Yadav, Dhirendra, additional, Joshi, Anagha, additional, Badgujar, Harshal, additional, Trivedi, Mayuri, additional, Shah, Priyanshu, additional, and Bhavsar, Prerna, additional

Published
2020
Full Text
View/download PDF

27. An outbreak of methicillin-resistant Staphylococcus aureus (MRSA) infection in dermatology indoor patients

Author

Sachdev, Deepa, Amladi, Sangeeta, Nataraj, Gita, Baveja, Sujata, Kharkar, Vidya, Mahajan, Sunanda, and Khopkar, Uday

Subjects
Antibiotics -- Health aspects, Vancomycin -- Health aspects, Staphylococcus aureus -- Diagnosis, Staphylococcus aureus -- Research, Methicillin -- Health aspects, Methicillin -- Research
Abstract

ABSTRACT Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen. Indiscriminate and increased use of systemic antibiotics has led to the emergence of MRSA. Infected or colonized ward patients [...]

Published
2003

29. Surveillance of Healthcare-Associated Bloodstream and Urinary Tract Infections in a National Level Network of Indian Hospitals

Author

Mathur, Purva, primary, Malpiedi, Paul, additional, Walia, Kamini, additional, Malhotra, Rajesh, additional, Srikantiah, Padmini, additional, Katoch, Omika, additional, Katyal, Sonal, additional, Khurana, Surbhi, additional, Misra, Mahesh Chandra, additional, Gupta, Sunil, additional, Kumar, Subodh, additional, Sagar, Sushma, additional, Vig, Naveet, additional, Garg, Pramod, additional, Kapil, Arti, additional, Sahu, Manoj, additional, Chakrabarti, Arunaloke, additional, Ray, Pallab, additional, Biswal, Manisha, additional, Taneja, Neelam, additional, Rupali, Priscilla, additional, Chacko, Vellore Binila, additional, Michael, Joy Sarojini, additional, Balaji, Veeraraghavan, additional, Rodrigues, Camilla, additional, Nag, Vijaya Lakshmi, additional, Tak, Vibhor, additional, Venkatesh, Vimala, additional, Mukhopadhyay, Chiranjay, additional, Vandana, KE, additional, Varma, Muralidhar, additional, Deotale, Vijayshri, additional, Attal, Ruchita, additional, Padmaja, Kanne, additional, Wattal, Chand, additional, Goel, Neeraj, additional, Bhattacharya, Sanjay, additional, Karuna, Tadepalli, additional, Saigal, Saurabh, additional, Behera, Bijayini, additional, Singh, Sanjeev, additional, Thirunarayan, MA, additional, Nath, Reema, additional, Ray, Raja, additional, Baveja, Sujata, additional, Chandy, Mammen, additional, Mukherjee, Sudipta, additional, Roy, Manas, additional, Goel, Gaurav, additional, Tripathy, Swagata, additional, Misra, Satyajeet, additional, Dey, Anupam, additional, Mishra, Tushar, additional, Raj, Hirak, additional, Fomda, Bashir, additional, Bashir, Gulnaz, additional, Nazir, Shaista, additional, Devi, Sulochana, additional, Devi, Khuraijam Ranjana, additional, Singh, Langpoklakpam Chaoba, additional, Das, Padma, additional, Bhargava, Anudita, additional, Gaikwad, Ujjwala, additional, Khandelwal, Neeta, additional, Vaghela, Geeta, additional, Sukharamwala, Tanvi, additional, Verma, Prachi, additional, Lamba, Mamta, additional, Jain, Shristi, additional, Bhattacharyya, Prithwis, additional, Phukan, Anil, additional, Lyngdoh, Clarissa, additional, Sharma, Rajeev, additional, Gaind, Rajni, additional, Saksena, Rushika, additional, Kapoor, Lata, additional, Gupta, Neil, additional, Sharma, Aditya, additional, VanderEnde, Daniel, additional, Velayudhan, Anoop, additional, Siromany, Valan, additional, Laserson, Kayla, additional, and Guleria, Randeep, additional

Published
2020
Full Text
View/download PDF

32. In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016–18

Author

Appalaraju, Boppe, primary, Baveja, Sujata, primary, Baliga, Shrikala, primary, Shenoy, Suchitra, primary, Bhardwaj, Renu, primary, Kongre, Vaishali, primary, Dattatraya, Gogi Suresh, primary, Dhole, Tapan, primary, Verma, Binita, primary, Mukherjee, D N, primary, Gupta, Shalini, primary, Shanmugam, Priyadarshini, primary, Iravane, Jyoti, primary, Mishra, Sudhi Ranjan, primary, Barman, Purabi, primary, Chopra, Shimpi, primary, Hariharan, Meenakshi, primary, Surpam, Rajendra, primary, Pratap, Rana, primary, Joshi, Prashant, primary, Khande, Hemant, primary, Mane, Ashish, primary, Jain, Rishi, primary, and Bhagwat, Sachin, primary

Published
2019
Full Text
View/download PDF

33. A clinico-mycological study of onychomycosis at a tertiary care center

Author

Tendolkar Uma Mahesh, Attar Farhana Iqbal, Baveja Sujata Mukesh, Phiske Meghna, and Dhurat Rachita

Subjects
di-methyl sulfoxide (dmso), medicine.medical_specialty, dermatophytes, business.industry, Direct microscopy, lcsh:R, lcsh:Medicine, potassium hydroxide (koh), Tertiary care hospital, Dermatology, Tertiary care, Surgery, medicine.anatomical_structure, nondermatophytes, Etiology, medicine, Nail (anatomy), onychomycosis, Outpatient clinic, Fungal morphology, General Agricultural and Biological Sciences, business, KOH preparation
Abstract

Background: Onychomycosis continues to be worldwide problem constituting a large bulk of cases attending the dermatology outpatient department. Fungal infections of nails have been partly studied,because it has been considered more of a cosmetic problem than a health problem. Although not life threatening, onychomycosis may have significant clinical consequences such as secondary bacterial infection, chronicity, therapeutic difficulties and disfigurement, in addition to serving as reservoir of infection. Aims and Objectives: To find out the prevalence, etiology and clinico-mycological correlation of onychomychosis among clinically suspected cases. To compare the microscopy findings using potassium hydroxide (KOH) preparation with potassium hydroxide- dimethyl sulfoxide (KOH-DMSO/DMSO) preparation. To compare demographic and clinical data inonychomycosis and fungus negative groups Material and Methods: The study was conducted from October 2011 to October 2013, in the department of Microbiology of a tertiary care hospital in Mumbai, including 204 patients clinically suspected of onychomycosis. Nail scrapings were collected depending upon site, type of nail involvement and subjected for microscopic examination using 20% KOH and KOH DMSO (10-40%), followed by fungal culture. Results: Out of 204 patients, 78 (38.2 %) were diagnosed having onychomycosis, 72 (92.3%) patients were positive by direct microscopy and 45 (57.7%) by culture. DMSO preparation offered a faster clearing of background but in KOH preparation fungal morphology was better maintained even after 24 hours. In culture positive cases, isolation of dermatophytes was most common (42.2%), followed by Candida species (31.1%) and nondermatophytes (26.7%). Conclusion: This concludes that laboratory diagnosis of onychomycosis is essential as many conditions of nail mimic onychomycosis. Though commonest causative agents of onychomycosis are dermatophytes, number of cases caused by Candida species and nondermatophytesare on the rise. Asian Journal of Medical Sciences Vol.8(1) 2017 48-57

Published
2017

34. Report: Medical students for monitoring biomedical waste segregation practices -why and how? Experience from a medical college

Author

Nataraj, Gita, Baveja, Sujata, Kuyare, Sunil, Poojary, Aruna, Mehta, Preeti, Kshirsagar, Nilima, and Gogtay, Nithys

Subjects
Medical wastes -- Waste management -- Research -- Methods, Medical students -- Research -- Methods, Refuse and refuse disposal -- Methods -- Influence -- Research, Environmental services industry, Influence, Waste management, Research, Methods
Abstract

Byline: Gita Nataraj (Department of Microbiology, Seth G.S Medical College and K.E.M Hospital, Mumbai, India, gitanataraj@gmail.com); Sujata Baveja (Department of Microbiology, Seth G.S Medical College and K.E.M Hospital, Mumbai, India); [...]

Published
2008
Full Text
View/download PDF

37. Preventing infection from indwelling intravascular devices: Hospital infection society India consensus group recommendations for Indian healthcare

Author

Sardana, Raman, primary, Mandal, AmitKumar, additional, Nair, Deepthi, additional, Mendiratta, Leena, additional, Butta, Hena, additional, Jain, TS, additional, Kapil, Arti, additional, Wattal, Chand, additional, Hans, Charoo, additional, Mani, RK, additional, Sagar, Gaurav, additional, Jaggi, Namita, additional, Khilnani, Praveen, additional, Mathur, Purva, additional, Jasuja, Sanjiv, additional, Kansal, Sudha, additional, Manchanda, Vikas, additional, Nangia, Vivek, additional, Sharma, Anita, additional, Khan, Fatima, additional, Mehta, Geeta, additional, Nataraj, Gita, additional, Kelkar, Rohini, additional, Todi, Subhash, additional, Baveja, Sujata, additional, Balaji, V, additional, Gupta, Aarti, additional, Arora, Anita, additional, Gupta, Anu, additional, Hasan, Azra, additional, Raman, LakshmyA, additional, Choudhry, Madhu, additional, Haider, Mahvash, additional, Mani, Manju, additional, Rathor, Neha, additional, Aggarwal, Nitika, additional, Barman, Purabi, additional, Kaur, Ravneet, additional, Malhotra, Shalini, additional, Malik, SoniaKhatter, additional, Kumar, Suresh, additional, Chugh, TD, additional, Malhotra, VL, additional, Patwardhan, Vrushali, additional, Stephens, Angela, additional, Ligin, Reena, additional, Kumari, Sapna, additional, and Singh, Shilpi, additional

Published
2019
Full Text
View/download PDF

38. Trichosporon inkin and Trichosporon mucoides as unusual causes of white piedra of scalp hair

Author

Tendolkar, Uma, Shinde, Alka, Baveja, Sujata, Dhurat, Rachita, and Phiske, Meghana

Subjects
Hair diseases -- Causes of -- Diagnosis -- Case studies -- Reports, Mycoses -- Diagnosis -- Case studies -- Reports, Health, Diagnosis, Case studies, Reports, Causes of
Abstract

Byline: Uma. Tendolkar, Alka. Shinde, Sujata. Baveja, Rachita. Dhurat, Meghana. Phiske White piedra of scalp hair is considered a rare entity. We report three cases of this disorder all of [...]

Published
2014

39. In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016-18.

Author

Appalaraju, Boppe, Baveja, Sujata, Baliga, Shrikala, Shenoy, Suchitra, Bhardwaj, Renu, Kongre, Vaishali, Dattatraya, Gogi Suresh, Dhole, Tapan, Verma, Binita, Mukherjee, D N, Gupta, Shalini, Shanmugam, Priyadarshini, Iravane, Jyoti, Mishra, Sudhi Ranjan, Barman, Purabi, Chopra, Shimpi, Hariharan, Meenakshi, Surpam, Rajendra, Pratap, Rana, and Joshi, Prashant

Subjects
*ANTIBACTERIAL agents, *ACINETOBACTER baumannii, *STREPTOCOCCUS pneumoniae, *STAPHYLOCOCCUS aureus, *ANTIBIOTICS, *STAPHYLOCOCCUS, *DIABETIC foot, *RESEARCH, *HETEROCYCLIC compounds, *RESEARCH methodology, *METHICILLIN-resistant staphylococcus aureus, *MEDICAL cooperation, *EVALUATION research, *COMPARATIVE studies, *QUINOLONE antibacterial agents, *LONGITUDINAL method, *MICROBIAL sensitivity tests, *PHARMACODYNAMICS
Abstract

Background: Levonadifloxacin is a novel antibiotic belonging to the benzoquinolizine subclass of fluoroquinolones with potent activity against MRSA and quinolone-resistant Staphylococcus aureus. IV levonadifloxacin and its oral prodrug alalevonadifloxacin have recently been approved in India for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) including diabetic foot infections.Objectives: To investigate the in vitro activity of levonadifloxacin against contemporary clinical isolates collected from multiple tertiary care hospitals across India in the Antimicrobial Susceptibility Profiling of Indian Resistotypes (ASPIRE) surveillance study.Methods: A total of 1376 clinical isolates, consisting of staphylococci (n = 677), streptococci (n = 178), Enterobacterales (n = 320), Pseudomonas aeruginosa (n = 140) and Acinetobacter baumannii (n = 61), collected (2016-18) from 16 tertiary hospitals located across 12 states in India, were included in the study. The MICs of levonadifloxacin and comparator antibiotics were determined using the reference agar dilution method and broth microdilution method.Results: Levonadifloxacin exhibited potent activity against MSSA (MIC50/90: 0.5/1 mg/L), MRSA (MIC50/90: 0.5/1 mg/L) and levofloxacin-resistant S. aureus (MIC50/90: 1/1 mg/L) isolates. Similarly, potent activity of levonadifloxacin was also observed against CoNS including MDR isolates (MIC50/90: 1/2 mg/L). Against Streptococcus pneumoniae, levonadifloxacin (MIC50/90: 0.5/0.5 mg/L) showed superior activity compared with levofloxacin (MIC50/90: 1/2 mg/L). Among levofloxacin-susceptible Enterobacterales, 80.6% of isolates were inhibited at ≤2 mg/L levonadifloxacin.Conclusions: Levonadifloxacin displayed potent activity against contemporary MRSA and fluoroquinolone-resistant staphylococcal isolates, thus offering a valuable IV as well as an oral therapeutic option for the treatment of ABSSSIs. Furthermore, levonadifloxacin exhibited a broad-spectrum activity profile as evident from its activity against streptococci and levofloxacin-susceptible Gram-negative isolates. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

43. Prevalence of metallo-[beta]-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in intensive care areas in a tertiary care hospital

Author

De, Anuradha, Kumar, Simit, and Baveja, Sujata

Subjects
Intensive care units -- Management, Infection -- Control, Antibiotics -- Health aspects -- Research, Pseudomonas aeruginosa -- Physiological aspects -- Research, Company business management, Health
Abstract

Byline: Anuradha. De, Simit. Kumar, Sujata. Baveja A total of 39 non-duplicate isolates of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter species isolated from blood and endotracheal secretions were tested for metallo-ß-lactamase [...]

Published
2010

44. Microbial Etiology of Febrile Neutropenia

Author

Nataraj Gita, Mudshingkar Swati, Baveja Sujata, Jijina Farah, and Mehta Preeti

Subjects
Voriconazole, Antiinfective agent, biology, business.industry, medicine.drug_class, Klebsiella pneumoniae, Antibiotics, Hematology, Neutropenia, medicine.disease, biology.organism_classification, Antimicrobial, Microbiology, Sepsis, Medicine, Original Article, business, Febrile neutropenia, medicine.drug
Abstract

Bacterial and fungal infections are a major cause of morbidity and mortality among neutropenic patients. The choice of empiric antimicrobial regimen is based on susceptibility pattern of locally prevalent pathogens. From 64 febrile neutropenic patients with clinical sepsis, blood and other appropriate clinical specimens were processed to determine bacterial and fungal spectrum and their antimicrobial susceptibility pattern. Risk factors for developing sepsis were determined by case–control study. 68 organisms were recovered. Fifteen (22.05%) were Gram-positive cocci with predominance of methicillin Sensitive S. aureus (10.29%), 47 (69.11%) were Gram-negative rods with predominance of Klebsiella pneumoniae (30.88%) and four were Non albicans Candida. 81% and 60% of Klebsiella and E. coli were ESBL producers. All species of Candida were sensitive to amphoterecin B and voriconazole. Duration and extent of neutropenia, chemotherapy, immunosuppressive therapy, altered mucosal barriers and presence of central venous lines were statistically significant risk factors for developing sepsis. Gram-negative bacteria were the predominant isolates. The choice of therapy in neutropenic patients should be formulated based on local spectrum of microbes and local and regional resistance patterns.

Published
2010
Full Text
View/download PDF

45. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in community-acquired primary pyoderma

Author

Patil, Rahul, Baveja, Sujata, Nataraj, Gita, and Khopkar, Uday

Subjects
Staphylococcus aureus -- Surveys, Staphylococcus aureus -- Risk factors, Staphylococcus aureus -- Care and treatment
Abstract

Byline: Rahul. Patil, Sujata. Baveja, Gita. Nataraj, Uday. Khopkar Background: Although prevalence of MRSA strains is reported to be increasing, there are no studies of their prevalence in community-acquired primary [...]

Published
2006

Catalog

Books, media, physical & digital resources
See catalog results